Intel's stock is experiencing its most powerful consecutive rally on record, though analysts caution that valuations have become rich, potentially limiting further upside. On Monday, Intel shares closed up 4.52%, marking the ninth straight session of gains and setting a record for the best nine-day winning streak in its history. According to Dow Jones Market Data, the stock has surged approximately 58.29% during this period and has gained about 40% over the past month.
The core drivers behind this rally include a recovery in server CPU demand, product price increases, and a chip manufacturing cooperation agreement with Terafab, a company associated with Elon Musk. However, UBS analyst Timothy Arcuri noted in a Monday research report that Intel's current stock price implies a multiple of about 20 times the optimistic consensus earnings estimate for 2030, "suggesting limited upside from current levels." Despite this, he still expects the stock to exhibit an "upward bias" for the remainder of the year.
Server CPU Demand Recovers, Prices Increase About 10% Arcuri stated that ahead of Intel's quarterly earnings report at the end of the month, he anticipates strong results and guidance, primarily based on "resilient" personal computer demand and server CPU demand that is "materially improving." Notably, Intel has raised server CPU prices by approximately 10%. Arcuri expects demand to continue climbing this year, especially in the enterprise segment—which he estimates accounts for about 60% of Intel's total server CPU revenue.
Musk's Terafab Partnership Puts Spotlight on Ohio Fab Prospects Recently, Intel has signed multiple chip manufacturing agreements, boosting investor and Wall Street confidence in the prospects for its foundry business. Earlier this month, Intel announced a partnership with Terafab, focused on manufacturing chips for Tesla, SpaceX, and xAI. Arcuri pointed out that if Intel's Ohio fab integrates with this joint venture, "it would further bolster confidence in the foundry business outlook." However, given the time required to establish operations, this is more of a long-term narrative. Additionally, Intel announced the repurchase of the 49% stake it held in the joint venture related to its Fab 34 facility in Ireland. Arcuri had previously described this move as "an important first step in re-injecting operating leverage into its fab funding model."
14A Process Node: Key Catalyst for Foundry Business Awaited Arcuri views the upcoming release of the Process Design Kit (PDK) for Intel's 14A process node as a "key catalyst for the foundry business." Wall Street widely believes the 14A process is crucial for Intel to attract external customers and regain leadership in chip manufacturing. However, Arcuri also acknowledged in Monday's report that, even considering Intel's buyback of its stake in the Semiconductor Co-Investment Program (SCIP) for its Arizona fab from Brookfield Asset Management, he currently retains doubts about Intel's long-term profitability. Intel's SCIP mechanism allows it to co-invest with external partners to support manufacturing expansion while retaining majority control.
Comments